A Single-Dose Study to Evaluate Safety and Efficacy of CS-1103 in Participants Receiving a Single Dose of Methamphetamine

Clinical trial NCT06721494 · RECRUITING

Trial details

NCT number: NCT06721494
Sponsor: Clear Scientific, Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Methamphetamine Intoxication Methamphetamine Disorders Methamphetamine Abuse

Start date: 2026-02-05
Primary completion: 2026-09-04
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.